Analyst Ratings for Inovio Pharmaceuticals (INO)
INO Rating Summary
INO Price Target Summary
- Highest: $8.00 (BofA Securities)
- Lowest: $1.00 (Stifel)
- Average: $5.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$5.00 (+157.7%)
* Over Last 12-Mos
Rating Score: 4.7 / 10
Percentile Rank: 44%
Avg. $ Target:
$5.00 (+157.7%)
* Over Last 12-Mos
Rating Score: 4.7 / 10
Percentile Rank: 44%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/11/2022 | Oppenheimer | Hartaj Singh | Downgrade | Perform (Outperform) |
N/A (N/A) |
2.49 (1.94) |
-22.09% | Details |
| 1/21/2022 | BofA Securities » Updated 5/17/2022 |
Geoff Meacham | Upgrade | Neutral (Underperform) |
8.00 (9.00) |
4.10 (1.94) |
-52.68% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
